Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to -$46.7 million.

  • Surgery Partners' Net Cash Flow fell 66265.06% to -$46.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.4 million, marking a year-over-year decrease of 2957.75%. This contributed to the annual value of $73.6 million for FY2024, which is 18459.77% up from last year.
  • Per Surgery Partners' latest filing, its Net Cash Flow stood at -$46.7 million for Q3 2025, which was down 66265.06% from $20.8 million recorded in Q2 2025.
  • Surgery Partners' 5-year Net Cash Flow high stood at $223.7 million for Q1 2021, and its period low was -$151.5 million during Q2 2022.
  • Moreover, its 5-year median value for Net Cash Flow was -$11.0 million (2022), whereas its average is -$6.0 million.
  • As far as peak fluctuations go, Surgery Partners' Net Cash Flow soared by 21895.26% in 2024, and later plummeted by 66265.06% in 2025.
  • Quarter analysis of 5 years shows Surgery Partners' Net Cash Flow stood at $59.5 million in 2021, then skyrocketed by 115.29% to $128.1 million in 2022, then crashed by 131.3% to -$40.1 million in 2023, then soared by 218.95% to $47.7 million in 2024, then crashed by 197.9% to -$46.7 million in 2025.
  • Its last three reported values are -$46.7 million in Q3 2025, $20.8 million for Q2 2025, and -$40.2 million during Q1 2025.